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Abstract 
 
The Schizotypal Personality Questionnaire-Brief (SPQ-B) was developed with 
the aim of examining variations in healthy trait schizotypy, as well as latent 
vulnerability to psychotic-spectrum disorders. No previous study has studied the cross-
cultural validity of the SPQ-B in a large cross-national sample. The main goal of the 
present study was to analyze the reliability and the internal structure of SPQ-B scores in 
a multinational sample of 28,426 participants recruited from 14 countries. The mean age 
was 22.63 years (SD = 7.08; range 16-68 years), 37.7% (n = 10,711) were men. The 
omega coefficients were high, ranging from 0.86 to 0.92 for the total sample. 
Confirmatory factor analysis revealed that SPQ-B items were grouped either in a 
theoretical structure of three first-order factors (Cognitive-Perceptual, Interpersonal, and 
Disorganized) or in a bifactor model (three first-order factors plus a general factor of 
schizotypal personality). In addition, the results supported configural but not strong 
measurement invariance of SPQ-B scores across samples. These findings provide new 
information about the factor structure of schizotypal personality, and support the 
validity and utility of the SPQ-B, a brief and easy tool for assessing self-reported 
schizotypal traits, in cross-national research. Theoretical and clinical implications for 
diagnostic systems, psychosis models, and cross-national mental health strategies are 
derived from these results. 
 
Keywords: Schizotypy; Schizotypal personality; Psychosis; Cross-cultural; SPQ-B; 
Psychosis risk 
 
 
 
  
 
 
1. Introduction 
  In the past two decades, the early and reliable identification of individuals 
potentially at-risk for psychotic-spectrum disorders, based on psychometric indices, has 
become a focus of extensive and expanding research and debate (Addington et al., 2015; 
Fonseca-Pedrero et al., 2016b; Fusar-Poli et al., 2014; Kline and Schiffman, 2014; 
Mason, 2015). The identification of specific subgroups of individuals at high risk for 
psychotic-spectrum disorders may help us to elucidate risks and protective factors, as 
well as etiological mechanisms and developmental pathways that mitigate, delay, or 
even prevent the onset of  clinically significant psychotic disorders (Barrantes-Vidal et 
al., 2015).  
Schizotypal traits are considered a phenotypic-indicator of schizotypy (Meehl, 
1962), a latent personality organization reflecting a putative liability for schizophrenia-
spectrum disorders (Barrantes-Vidal et al., 2015; Fonseca Pedrero and Debbané, 2017; 
Lenzenweger, 2010). Schizotypal traits encompass anomalies and deficits across 
cognitive (e.g., paranoid ideation, ideas of reference), social/emotional (e.g., anhedonia, 
no close friends), and behavioural (e.g., odd behaviour and language) systems (Cohen et 
al., 2015; Fonseca-Pedrero et al., 2017). Previous findings support the notion of 
assumed phenomenological, temporal, and etiological continuity between the 
subclinical and clinical psychosis phenotype and lend validity to the concept of 
schizotypal traits (Cohen et al., 2015; Ettinger et al., 2014; Linscott and van Os, 2013). 
Several measurement instruments allow clinicians and researchers to document 
the presence, frequency, and severity of schizotypal traits (Fonseca-Pedrero et al., 
2016b; Mason, 2015). These tools have been developed with the aim of examining 
variation in healthy trait schizotypy as well as latent vulnerability to psychotic-spectrum 
disorders in both clinical and non-clinical population (e.g., general population, clinical, 
and genetic high risk samples). The Schizotypal Personality Questionnaire (SPQ) 
(Raine, 1991), in its brief version (SPQ-B) (Raine and Benishay, 1995), or its brief 
revised version (SPQ-BR) (Cohen et al., 2010), measure a broad range of psychotic-like 
traits– originally nine identified subordinate traits based on the operational definition of 
Schizotypal Personality Disorder (SPD) (American Psychiatric Association, 1987), and 
is among the more widely-used measured of this type.  
The SPQ-B has been used with patients and relatives of patients with 
schizophrenia-spectrum disorders (Compton et al., 2007; Moreno-Izco et al., 2015), 
adolescents (Fonseca-Pedrero et al., 2009), twins (Ericson et al., 2011), outpatients 
(Axelrod et al., 2001), and college students (Compton et al., 2009a; Fonseca-Pedrero et 
al., 2011; Mata et al., 2005; Raine and Benishay, 1995). The psychometric properties of 
the SPQ-B have been examined previously. For instance, the reliability of scores and 
several sources of evidence of validity have been demonstrated (e.g., Fonseca-Pedrero 
et al., 2016b; Mason, 2015). Moreover, translations of the measure have been validated 
in several countries (e.g., France, China, Spain, Turkey, Switzerland, etc.) (e.g., 
Aycicegi et al., 2005; Ma et al., 2015; Ortuño-Sierra et al., 2013). 
Examination of the SPQ-B factor structure has yielded factorial solutions of two  
(Aycicegi et al., 2005), three (Compton et al., 2009a; Fonseca-Pedrero et al., 2011, 
2009; Ma et al., 2015; Mata et al., 2005; Ortuño-Sierra et al., 2013; Tran et al., 2015), 
and four factors (Cohen et al., 2010; Fonseca-Pedrero et al., 2010). The three-factor 
model characterized by Cognitive-Perceptual (e.g., hallucinations, ideas of reference, 
magical thinking or paranoid ideation), Interpersonal (e.g., blunted affect, social anxiety 
or lack of close friends), and Disorganized (e.g., odd behavior and speech) dimensions 
has been widely replicated across studies. However, although the underlying structure 
of schizotypal personality, as assessed via the SPQ-B, has been analyzed, previous 
research has produced some contradictory results. These mixed findings are partially 
explained by variations in sampling method (random, convenience), sample 
characteristics (clinical, non-clinical, and country), and the data-analytic approach 
employed (exploratory vs. confirmatory factor analysis).  
To the best of our knowledge, no previous studies has validated the 
psychometric quality of SPQ-B scores across multiple countries. For instance, we have 
little information about the factorial structure of SPQ-B scores and its possible variation 
across countries, particularly non-Western countries. Moreover, as previous studies 
have demonstrated with the SPQ, alternative models (e.g., Barron et al., 2017; Preti et 
al., 2015) may better explain the latent structure of SPQ-B scores. Thus, it is important 
to gather new information about the validity of this tool through cross-cultural research 
and collaborative multinational studies. Furthermore, and despite the globalization of 
psychosis research, no previous study has analyzed the psychometric quality of 
psychosis risk screeners in multinational samples. 
The purpose of the present study was to analyze the psychometric properties of 
SPQ-B scores in a large sample recruited from 14 countries. Derived from this main 
goal are the following specific objectives: a) to estimate the reliability of SPQ-B scores 
across countries; b) to study the internal structure of SPQ-B scores across countries; and 
c) to analyze the measurement invariance of SPQ-B scores across countries. We
hypothesized that the three-factor model of the SPQ-B would have adequate goodness-
of-fit indices across samples. Moreover, we hypothesized that new measurement 
models, such as a bifactor model, would fit adequately. In addition, we further 
hypothesized that SPQ-B scores would show configural measurement invariance across 
samples.  
2. Method
2.1. Participants 
Participants were gathered from 24 sites across 14 countries (Australia, Austria, 
Belgium, Canada, China, Germany, Greek, Italy, Mauritius, New Zealand, Spain, 
Tunisia, United States of America, and United Kingdom). Data from the present study, 
focused on reporting of full SPQ scores, has been published elsewhere (Fonseca-
Pedrero et al., 2017) and the present study focused specifically on the SPQ-B. The 
overall sample consisted of 28,426 participants. The mean age was 22.63 years (SD = 
7.08; range 16-68 years). A total of 14.5% (n = 4,113) of participants did not provide 
age. Participant were 10,711 males (37.7%) and 17,208 females (60.5%); 507 (1.8%) 
did not specify sex. Thus, 27,919 (98.2%) participants reported sex and 22,888 
(80.52%) reported age. In this study, we considered information at the country, and not 
research site, level. Information about the age, sex, and other participant characteristics 
are reported in Table 1. Information about sampling procedures and demographic 
characteristics of the samples across sites are presented in the Supplementary Materials.  
---------------------------------------------Insert Table 1-------------------------------------------- 
2.2. Instrument 
2.2.1. The Schizotypal Personality Questionnaire-Brief (SPQ-B) 
The SPQ-B provides a common index of schizotypal traits across all countries. 
The SPQ-B is a 22-item (True/False) self-report scale based on the SPQ (Raine, 1991) 
for the assessment of SPD traits as defined by DSM-III-R diagnostic criteria (American 
Psychiatric Association, 1987). The SPQ-B includes items that fall within three 
domains: Cognitive-Perceptual (ideas of reference, paranoid ideation, magical thinking, 
  
 
and unusual perceptual experiences), Interpersonal (social anxiety, no close friends, 
blunted affect, and paranoid ideation), and Disorganized (odd speech and behavior). In 
the present study, the items of the brief version were extracted from the original SPQ 
validated for each country. Item selection was based on the original brief SPQ: English 
(Raine, 1991), Spanish (Fonseca-Pedrero et al., 2014b), Italian (Fossati et al., 2003), 
Chinese (Chen et al., 1997), Arabic (Lahmar et al., 2014), French  (Dumas et al., 2000), 
Creole (Reynolds et al., 2000), Greek (Tsaousis et al., 2015), and German version 
(Klein et al., 1997).  
 
2.3. Procedure 
Conventions for obtaining informed consent required by each investigator’s 
research institution, as well as IRB or ethical committees were followed. All 
participants provided written informed consent prior to participation. The study was 
conducted in accordance with the guidelines of the Declaration of Helsinki (World 
Medical Association, 2013). In the present study the SPQ-B scores being reported are 
derived from the administration of the full 74 item SPQ (see Fonseca-Pedrero et al., 
2017). Similarly, the SPQ was sometimes administered in the context of larger studies 
(see Supplemental Material for further information).  
 
2.4. Data analyses 
Descriptive statistics for the items of the SPQ-B items were calculated as the 
first step. In order to test the reliability of SPQ-B scores, and due to the limitations of 
Cronbach’s α (Dunn et al., 2014), coefficient ω was estimated (Zinbarg et al., 2005). 
Next, in order to analyse the internal structure of SPQ-B scores, and based on previous 
literature, several confirmatory factor analyses (CFAs) were conducted at the item level. 
Considering the categorical nature of the data, we used the robust mean-adjusted 
weighted least square method (WLSMV) for parameter estimation (Muthén and 
Muthén, 1998-2012). The following goodness-of-fit indices were used: Chi-square (χ2), 
Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), Root Mean Square Error of 
Approximation (RMSEA), and Weighted Root Mean Square Residual (WRMR). CFI 
and TLI values greater than .95 are preferred and those close to .90 are considered 
acceptable; RMSEA values should be under .08 for a reasonable fit, and under .05 for a 
good fit, whereas WRMR values less than .08 are considered evidence of good model 
(Brown, 2006; Hu and Bentler, 1999). 
  
 
 Taking into account previous studies, different measurement models were tested: 
a) a unidimensional model; b) a bidimensional solution with a Cognitive-Perceptual,  
and a Negative factor (Siever and Gunderson, 1983); c) the Raine et al. (1994) model 
that includes Cognitive-Perceptual, Interpersonal, and Disorganized dimensions with 
Items 7, 9, 14, and 17 overlapping (i.e., cross-loading) in both the Cognitive-Perceptual 
and Interpersonal dimensions; d) the Raine and Benishay (1995) three-factor solution 
with no item cross-loadings allowed, and; e) a bifactor model that includes a general 
factor of schizotypal personality and three first order factors (Cognitive-Perceptual,, 
Interpersonal, and Disorganized). Correlations among error terms were not permitted. 
Finally, and with the aim of studying measurement invariance across countries, we 
conducted successive multi-group CFAs models (MGCFAs models) for categorical 
outcomes (Muthén and Asparouhov, 2002). 
The relatively few missing values in the data were replaced by regression-based 
estimates, to which an error component was added, based on the SPSS Missing Value 
Analysis module. SPSS 22.0 (IBM Corp Released, 2013), Mplus 7.4 (Muthén and 
Muthén, 1998-2012), FACTOR 10.5 (Ferrando and Lorenzo-seva, 2017), and R (R 
Development Core Team, 2011) were used for the data analyses. 
 
3. Results 
3.1 Descriptive statistics and internal consistency of the SPQ-B scores 
 Means and standard deviations for the SPQ-B items for all countries are shown 
in Table 2. Internal consistency values for SPQ-B scores in the total sample and by 
country are shown in Table 3. Omega coefficients were adequate for data from all 
participating countries. Values for the total sample were 0.86, 0.91, 0.89, and 0.92 for 
the Cognitive-Perceptual, Interpersonal, and Disorganized subscales, and the Total 
score, respectively. Across countries, values ranged from 0.77 (Cognitive-Perceptual for 
China) to 0.94 (total score for the United States, Interpersonal and Disorganization for 
Germany). 
 
--------------------------------------Insert Table 2 and 3-------------------------------------------- 
 
3.2. Internal structure of schizotypal traits  
  
 
Goodness-of-fit indices for the analyzed models are presented in Table 4. As can 
be seen, the models that showed the best fit in all the countries were the bifactor and 
Raine et al. (1994) models (models c and e). The bifactor model displayed better 
goodness-of-fit indices, but, as explained below, the factor loadings in this solution 
revealed some inconsistencies. It is worth noting that, in several countries, some of the 
goodness-of-fit indices such as CFI and TLI were close to the standard cut-off values, 
but still inadequate. In particular, values of CFI lower than .90 were observed in both 
models, especially in the model of Raine et al. Nonetheless, RMSEA values in both 
factorial solutions were good for all of the countries analyzed. As noted by Yu (2002), 
the RMSEA index may be preferred for analysis with the WLSMV estimator and 
ordered categorical variables. Thus, by this standard, the goodness-of-fit indices for the 
analyzed models could be considered adequate.    
Tables 5 and 6 show the factor loadings for each of the 22 items for the Raine et 
al. (1994) and the bifactor models, respectively. In addition, the means and range of the 
factor loadings for the SPQ-B items in the two models are presented. In the case of the 
Raine et al. (1994) model, correlations among the latent variables were calculated, with  
averages of 0.561 (Cognitive-Perceptual-Disorganized), 0.286 (Positive-Interpersonal), 
and 0.593 for the total sample. As can be seen, some factor loadings on the latent factors 
of the bifactor model were negative and nominally not significant, thus suggesting that 
this model could be further improved. Factor loadings for the Raine et al. (1994) model 
were all adequate and statistically significant. 
 
--------------------------------------Insert Table 5 and 6-------------------------------------------- 
 
3.3. Measurement invariance of the SPQ-B scores across countries 
Measurement invariance across all participating countries was studied for the 
two models that displayed best fit, namely the Raine et al. (1994) model (χ2 = 19973.89; 
df = 2828; CFI = 0.912; TLI = 0.90; RMSEA = 0.055, with 95% CI: 0.054-0.055; 
WRMR = 8.62) and  the bifactor models (χ2 = 14564.89; df = 2618; CFI = 0.938; TLI = 
0.924; RMSEA = 0.047 with 95% CI: 0.047-0.048; WRMR = 7.01). The configural 
invariance model, in which no equality constraints were imposed, showed an adequate 
fit to the data for both models. Next, a strong invariance model was tested with the item 
thresholds and factor loadings constrained to equality across groups. The ΔCFI between 
the constrained and the unconstrained models was over 0.01, indicating that strong 
  
 
invariance was not supported in the case of the bifactor model (χ2 = 23498.71; df = 
3086; CFI = 0.895; TLI = 0.890; RMSEA = 0.057 with 95% CI: 0.056-0.058; WRMR = 
9.80). For the Raine et al. (1994) model, no convergence was found and the program did 
not allow us to calculate strong invariance parameters. The ΔCFI between the 
constrained and the unconstrained models was over 0.01, indicating that strong 
invariance was not supported. Hence, the results support configural invariance, whereas 
strong measurement invariance of the SPQ-B across the 14 countries studied was not 
tenable.  
 
4. Discussion 
The psychometric assessment of schizotypal traits offers distinctive benefits, 
such as being relatively inexpensive, non-invasive, and useful for screening large 
samples of the general population, as well as for identifying participants at increased 
risk for psychosis (e.g., Fonseca-Pedrero et al., 2016b; Lenzenweger, 2010; Mason, 
2015). For these purposes, and in tandem with global mental health research strategies, 
there is a clear need for psychometrically sound tools for both psychosis risk and 
schizotypal screening, which are validated across countries, to use in international 
research studies and diverse cultural settings. To date, no study has attempted to 
validate the SPQ-B in a cross-national sample. Furthermore, it remains unclear whether 
the factorial structure underlying SPQ-B scores is invariant across multiple countries. 
Thus, the main goal of the present study was to analyse the reliability, internal structure 
and measurement invariance by country of SPQ-B scores in a multinational sample of 
participants recruited from 14 countries.  
Our analyses highlighted several important findings. First, SPQ-B scores showed 
adequate levels of internal consistency across countries. The reliability of SPQ-B 
scores, estimated with coefficient omega, was generally above 0.8. This research 
provides further support for the reliability of the SPQ-B scores, extending previous 
findings to non-clinical samples from different countries and variable study contexts. 
Thus, the SPQ-B could be used as a screening instrument to identify individuals who 
may be at increased risk for psychosis-spectrum disorders as well as to examine 
variations in healthy trait schizotypy in cross-cultural studies. 
Second, examination of the factorial structure underlying the SPQ-B scores 
indicated that schizotypal traits have a multidimensional, rather than unidimensional, 
structure. SPQ-B items were grouped, in the present analysis, in a theoretical structure 
  
 
of three first-order factors (i.e., Cognitive-Perceptual, Interpersonal, and 
Disorganization dimensions) as well as in a bifactor model (three first-order factors plus 
general factor of schizotypal personality). In fact, this is the first study to show that it is 
possible to derive a total score for the SPQ-B and to obtain distinct subscores for the 
three classic schizotypal dimensions. Schizotypal personality is a multifaceted construct 
phenotypically similar to that found in patients with psychosis (e.g., Liddle, 1987). Just 
as the manifestation of schizophrenia is heterogeneous – encompassing a broad range of 
emotional, cognitive, perceptual, social and behavioral functions – schizotypy involves 
a diverse set of traits. Numerous studies, using the SPQ-B or its brief versions, have 
obtained evidence of such a three-factor structure for schizotypal personality (Compton 
et al., 2009a; Fonseca-Pedrero et al., 2011, 2009; Ma et al., 2015; Mata et al., 2005; 
Ortuño-Sierra et al., 2013; Tran et al., 2015), consistent with the Raine et al. (1994) 
model. Furthermore, the present results corroborate those found when comparing SPQ 
scores across samples (e.g., Bora and Arabaci, 2009; Compton et al., 2009b; Fonseca-
Pedrero et al., 2016a; Fonseca-Pedrero et al., 2017; Fossati et al., 2003; Raine et al., 
1994; Reynolds et al., 2000). Futhermore, this factorial structure is similar to those 
found in the new measure of schizotypy named the Multidimensional Schizotypy Scale 
(MSS) (Kwapil et al., in press). 
Third, multigroup CFA showed that the SPQ-B three-factor model had 
configural, but not strong measurement invariance, across countries. Similar results 
have been found in prior research using the SPQ and its brief versions, as well as other 
schizotypy tools (e.g., the short form of the Oxford-Liverpool Inventory of Feelings and 
Experiences and Chapman’s scales of psychosis proneness) (Cicero, 2015; Fonseca-
Pedrero et al., 2015, 2014a; Kwapil et al., 2012; Ortuño-Sierra et al., 2013). For 
instance, Ortuño-Sierra et al. (2013), when comparing the factorial equivalence of the 
SPQ-B between Spanish and Swiss adolescents, found that SPQ-B scores had configural 
and partial strong invariance across the two samples. In addition, the present results 
demonstrated that several items showed differential functioning by country. To date, 
differential item functioning (DIF) for psychosis risk or schizotypy measures has yet to 
be thoroughly addressed. In cross-cultural research, it is vital to test whether varied 
groups show differing probabilities of success on (or likelihood of endorsing) an item 
after matching on the underlying construct (e.g., schizotypy) that the item is intended to 
measure (Byrne et al., 2009; Zumbo, 2007). DIF is of particular importance in 
international, comparative, and cross-cultural research particularly in efforts to ensure 
fairness and equity in testing (Zumbo, 2007). The present findings suggest that some 
schizotypal traits reflecting emotion, behavior, and cognition may differ across 
countries, at least those that were included in the present study. In fact, schizotypal traits 
assessed in different cultures have the potential to provide us with information about 
cultural variations in social and affective functioning (Cohen et al., 2015). Similar 
results have been found when psychotic symptoms or psychotic-like experiences are 
analyzed in samples recruited around the world (Larøi et al., 2014; Nuevo et al., 2012; 
Woods et al., 2014). The finding of configural measurement equivalence across cultures 
provides essential evidence of construct validity for the schizotypal dimensions, as well 
as evidence of the cross-cultural validity of SPQ-B scores; however, examination of 
DIF by sex, age, and language will be an important next step in future studies. 
The results of the present study should be considered in light of the following 
limitations. First, there is an inherent problem in the use of self-reports as indirect 
indicators of schizotypal traits. Second, the nature of the sample, composed of a 
majority of college students, precludes the generalization of the results to other 
populations of interest. Third, the fact that not all the samples employed the infrequency 
response to detect those participants who displayed random or pseudo-random patterns 
of responses may undermine the validity and generalizability of the results found in the 
present cross-national study.  Finally, in the present study, the items of the SPQ-B were 
extracted from the original full version of the SPQ. 
5. Conclusions
We have provided the first comprehensive validation study of the SPQ-B using a 
large, multinational sample from 14 countries. These results provides new information 
about the brief assessment of schizotypal traits using the same psychometric tool and 
analytic procedures to compare results obtained in different countries and linguistic 
groups. In addition, our results demonstrated that schizotypal personality is composed, 
at a minimum, of three dimensions (i.e., Cognitive-Perceptual, Interpersonal, and 
Disorganized), and is perhaps encompassed by a general schizotypal factor. The results 
derived from this cross-national study have theoretical and clinical implications for 
diagnostic systems, psychosis models, and cross-national mental health strategies. 
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the quality and clarity of the revised manuscript. In addition to this version, we 
also enclose point-by-point responses that describe the changes made to the 
manuscript in response to these reviewers’ comments and suggestions. You will 
find this commentary below, with our responses in italics. We hope you find 
these revisions to be in order and feel able to accept our manuscript for 
publication. However, if there are further issues requiring our attention, we 
would be grateful for a further opportunity to work together with you and your 
reviewers to rectify said issues. 
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Eduardo Fonseca-Pedrero 
 
Department of Educational Sciences, University of La Rioja, Spain 
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Centro de Investigación en Red de Salud Mental (CIBERSAM), Spain 
 
  
*Response to Reviewers
Reviewer 1. 
This is an analysis of a large set of samples of SPQ data across several 
countries to further examine the psychometric properties of the SPQ-B. The 
authors have compiled an impressive number of samples and are able to 
evaluate a number of models with these data. Overall results suggest some 
configural measurement invariance of the SPQ-B across countries. The report 
is competently written and the research area is important given the need for 1) 
brief and practical measures of schizotypy, and 2) cross-country, cross-ancestry 
investigation of schizotypy traits. This type of study fits in well with our attempts 
to square schizotypy models with a dimensional approach to psychopathology 
and a dimensional approach to risk for schizophrenia. However, several 
concerns should be addressed and clarity on these points will enhance the 
manuscript. 
We are appreciative of the time and care the Reviewer invested in 
helping us to improve the quality of our presentation. 
 
1)      Why SPQ-B from full SPQ data? It sounds like all of the samples were 
originally full SPQ—why whittle this down without reporting full results? 
Reasoning here remains unclear. 
We apologise that this aspect of our manuscript was not explained 
sufficiently clearly. The reason we focused on the SPQ-B data in the present 
study is because data from the full version of the SPQ has already been 
reported elsewhere (Fonseca-Pedrero et al., 2017). We now mention this point 
in the new version of our manuscript. Moreover, as compared to the previously 
reported work, here we are able to report on a larger dataset, which includes 
additional participants from the United Kingdom, as well as participants from 
two new countries (Germany and Austria). To repeat the point, the main goal of 
the present study was to study the brief version of the SPQ brief version, which 
has not previously been the subject of this sort of investigation. In our revision, 
we have added (in the Supplemental Material) two new tables that present 
sampling procedures and demographics characteristic of each subsample. 
 
2)      What were the procedures for imputing missing data from "regression-
based estimates"? i.e. what R package and function was used, parameters, etc. 
Using imputation in the study of psychometric properties should be justified in 
the Methods. 
We apologise for this oversight. As we now explain in our revision, based 
on the SPSS missing value analysis module, the relatively few missing values in 
the data were replaced by regression-based estimates to which an error 
component was added. 
 3)      There is a big focus on country, but not language or sex or culture. It feels 
like these are given no consideration despite plenty of power to do so. The 
authors could enhance the manuscript by exploring invariance across these 
constructs. 
 
  We agree that these are potentially useful ways for enhancing our 
manuscript. However, there are a number of separate issues that need to be 
considered. In terms of language, it may indeed be useful to examine invariance 
across language (as opposed to nation), but this would in fact greatly reduce 
the number of observed sampling cases in the present work. We believe it is 
more fruitful – and from a practical point of view, more substantive – to report on 
invariance at the level of the nation. Likewise, we agree that focusing on 
invariance across culture might be useful, but we do not believe there is an 
easy way of categorizing our samples based on a common definition of culture. 
That is, there are multiple ways in which “culture” could be defined, but no one 
definition would best serve our purposes in the present study. Moreover, due to 
space limitations, we made an a priori decision to focus on a singular factor 
(i.e., nation) in the present study. Nevertheless, we agree with the reviewer that 
there are opportunities to further interrogate this dataset and it is our plan to 
present a future manuscript that deals specifically with measurement invariance 
in terms of sex and age. 
 
Reviewer 2. 
This is a psychometric study of SPQ-B (i.e. one of the most popular self-
report tools for schizotypal traits) on a broad trans-national sample mostly 
based on college students. Despite the huge size (28,426 participants from 14 
countries), the nature of the sample (with the related limitations in terms of 
representativeness) constrains the impact and generalizability of the results. I 
herewith enlist some issues that could improve the import of the manuscript. 
 
1)      Methods: as "the items of the SPQ-B were extracted from the original full 
version of the SPQ", it could be important to present the whole SPQ data rather 
than circumscribing the analysis to SPQ-B. 
As detailed above, we report data from the full version of the SPQ 
elsewhere (Fonseca-Pedrero et al., 2017). However, given that both reviewers 
expressed interest in this issue, we have decided to add a new table in the 
supplemental material providing further information about the sample used in 
this cross-national study and the full dataset that we have compiled (please see 
eTable 1 and eTable 2). 
 2)      The results indicate that several items showed differential functioning by 
country. Please, expand and clarify. Which items? Why? Is there any clear and 
interpretable cultural trend? Also the consequences in terms of scoring should 
be discussed. 
We agree completely with this point. As noted, we have found that 
several items of the SPQ-B showed differential item functioning (DIF) by 
country. However, when using CFA, it is difficult to determine precisely which 
items show DIF because the approach involves making multiple simultaneous 
comparisons. For instance, in this study, 14 countries are represented. This 
means that we have to compare each country with every other country (in this 
case, that means making 14 x13 comparisons for each item of each dimension 
of the SPQ-B). The reviewer’s point is interesting and worthy of attention; 
however, space constraints preclude us from addressing this issue in depth in 
the present manuscript, given that our focus is on the validation of the SPQ-B. 
Nonetheless, in light of the importance of this issue, we have added new 
information about the DIF analyses that we conducted to the revised 
manuscript. Further, as clinicians and psychometrically oriented researchers, 
we concur that DIF analyses could be the focus of an additional manuscript and 
will explore that possibility. 
 
3)      The SPQ-B has a tentative cut-off score of 17 for the diagnosis of 
potential SPD in US. Do the authors expect such cut-off to be similar across 
other nations? 
That is an interesting issue and an excellent question. We think that, due 
to the country effects on SPQ-B scores that we observed, use of a uniform cut-
off score is inadvisable for at least two reasons. First, our results do not yield 
evidence of measurement invariance of SPQ-B scores by country. Second, in 
order to verify criterion validity as well as predictive validity, we would need to 
analyze SPQ-B scores in each country separately. We have added some 
information about this topic in the new version of the manuscript. 
 
4)      The sample apparently includes adolescents as well. Are SPQ-B features 
similar above and below 18 years age (at least in the countries where the data 
are available)? 
Adolescents (16-17 years old) constitute less than 0.8% of the omnibus 
sample of the present study. Moreover, in a study of the SPQ-B that the lead 
research team published in Schizophrenia Research, we found evidence of 
adequate psychometric properties in an adolescent samples (Fonseca-Pedrero, 
et al., 2009). 
 5)      Also, is there any evidence of an age-effect on schizotypal traits? 
As we mentioned above (Point 3, Reviewer 1), we intend to specifically 
investigate age invariance in a future study. Given space limitations, we do not 
feel we have the space to consider this issue in the present study. 
 
6)      Despite the intrinsic limitation of a psychometric study on college 
students, the authors mention "important theoretical and clinical implications for 
psychosis risk screening, etiological models of psychosis-spectrum disorders, 
and international diagnostic systems." I failed to find them in the manuscript. 
We agree and thank the reviewer for raising this point. We have modified 
the sentence to which the reviewer referred in the new version of the 
manuscript. We now highlight the relevance of conducting cross-national 
studies that examine psychosis and schizotypal personality traits. This is the 
first international study to examine the degree to which schizotypal traits 
manifest similarly across countries. We thus address an issue that is relevant to 
diagnostic classification systems (e.g., DSM) that treat this set of traits as 
equivalent across western and non-western countries. 
 
7)      It is not enirely clear how the full sample was generated. Perhaps merging 
the single study databases or each sub-study coordinator provided final data for 
its own sample? DO the author plan to make the final, anonymized dataset 
available on open-access? 
Thank you for raising this point. We have added information to the 
revised manuscript information about how we generated the full sample. Please 
see the Supplemental Material, Tables 1 and 2. While we agree in principle that 
data-sharing is important, we are unable to do so for the full dataset because 
not all collaborating partners have institutional and/or ethics permission to do 
so. Nevertheless, where permissible, interested readers are able to contact the 
corresponding author for information about individual datasets that may be 
shared, and the corresponding author will forward any such requests to 
individual collaborators.  
 
8)      The number of co-authors is massive (>30, presumably reflecting the 
administrative support in the single nation-studies that compose the final 
sample). Single-projects funding and support does not appear in the due 
section and might be worth specifying. 
In the present document we have included this information for all authors. 
As the reviewer, knows this manuscript was submitted to Schizophrenia 
Research with the approval of all co-authors. Not all projects had funding 
support, (e.g. Spain). We have added this information in the supplemental 
material and role funding source. 
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       Table 1 
         Demographic characteristics of the sample 
 Country Gender Age 
 n % Male Females M SD Range 
US 10,477 36.9 3,162 7,212 22.0 6.7 16-55 
Spain 1,123 4.0 224 899 20.2 2.0 18-29 
New Zealand 1,698 6.0 515 1,183 20.1 3.0 17-51 
Italy 649 2.3 305 344 24.3 3.5 19-38 
Australia 1,931 6.8 634 1,294 28.5 11.2 17-55 
Belgium 893 3.1 245 648 24.9 9.1 17-55 
UK 1,199 4.2 404 795 22.8 6.5 16-68 
Tunisia 458 1.6 137 321 20.4 1.4 18-29 
China 4,907 17.3 2,973 1,533 19.7 1.0 17-24 
Canada 1,849 6.5 562 1,287 20.8 2.9 18-53 
Greece 1,041 3.7 390 651 32.4 9.9 17-55 
Mauritius 1,201 4.2 688 513 23.4 1.2 21-27 
Austria 611 1.4 294 317 33.2 12.6 19-66 
Germany 389 2.1 178 211 32.7 13.2 19-66 
Total 28,426 100 10,711 17,208 22.63 7.08 16-68 
Table(s)
Table 2. Descriptive statistics for the SPQ-B across countries and total sample 
 
USA 
(n = 10,477) 
Spain 
(n = 1,123) 
New 
Zealand 
(n = 1,698) 
Italy 
(n = 649) 
Australia 
(n = 1,931) 
Belgium 
(n = 893) 
UK 
(n = 1,199) 
Tunisia 
(n = 458) 
China 
(n = 4,907) 
Canada 
(n = 1,849) 
Greece 
(n = 1,041) 
Mauritus 
(n = 1,201) 
 
Austria 
(n = 390) 
 
Germany 
(n = 610) 
Total 
Sample  
(N = 28,426) 
Items Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
1 0.32 0.47 0.46 0.50 0.23 0.42 0.38 0.49 0.42 0.49 0.47 0.50 0.42 0.49 0.53 0.50 0.31 0.46 0.30 0.46 0.43 0.50 0.41 0.49 0.29 0.45 0.26 0.44 0.34 0.48 
2 
0.4 0.49 0.30 0.46 0.38 0.49 0.26 0.44 0.51 0.50 0.34 0.47 0.48 0.50 0.36 0.48 0.45 0.50 0.29 0.45 0.23 0.42 0.26 0.44 0.27 0.44 0.27 0.45 0.38 0.49 
3 
0.31 0.46 0.30 0.46 0.28 0.45 0.31 0.46 0.26 0.44 0.33 0.47 0.34 0.47 0.54 0.50 0.31 0.46 0.27 0.45 0.28 0.45 0.47 0.50 0.15 0.36 0.15 0.36 0.31 0.46 
4 
0.24 0.43 0.34 0.48 0.25 0.44 0.27 0.45 0.33 0.47 0.28 0.45 0.31 0.46 0.37 0.48 0.69 0.46 0.24 0.43 0.35 0.48 0.19 0.39 0.13 0.34 0.11 0.31 0.34 0.47 
5 
0.36 0.48 0.46 0.50 0.25 0.43 0.32 0.47 0.39 0.49 0.30 0.46 0.33 0.47 0.68 0.47 0.85 0.36 0.30 0.46 0.35 0.48 0.37 0.48 0.25 0.43 0.23 0.42 0.44 0.50 
6 
0.16 0.37 0.42 0.49 0.14 0.34 0.09 0.29 0.17 0.38 0.10 0.30 0.26 0.44 0.12 0.33 0.13 0.34 0.12 0.33 0.07 0.26 0.18 0.38 0.12 0.32 0.12 0.33 0.16 0.37 
7 
0.24 0.43 0.17 0.37 0.17 0.38 0.29 0.45 0.15 0.35 0.25 0.44 0.24 0.43 0.57 0.5 0.09 0.29 0.23 0.42 0.38 0.49 0.61 0.49 0.13 0.34 0.07 0.26 0.22 0.42 
8 
0.19 0.39 0.13 0.34 0.13 0.34 0.18 0.38 0.14 0.35 0.28 0.45 0.23 0.42 0.48 0.5 0.37 0.48 0.17 0.37 0.15 0.36 0.28 0.45 0.19 0.4 0.16 0.37 0.22 0.41 
9 
0.3 0.46 0.18 0.38 0.31 0.46 0.12 0.33 0.28 0.45 0.22 0.41 0.38 0.49 0.27 0.44 0.16 0.36 0.27 0.44 0.17 0.37 0.34 0.48 0.15 0.35 0.12 0.33 0.25 0.44 
10 
0.35 0.48 0.22 0.42 0.34 0.48 0.12 0.33 0.34 0.47 0.13 0.34 0.36 0.48 0.24 0.43 0.21 0.41 0.32 0.47 0.13 0.33 0.36 0.48 0.38 0.49 0.31 0.46 0.30 0.46 
11 
0.38 0.49 0.34 0.48 0.33 0.47 0.15 0.35 0.45 0.50 0.30 0.46 0.36 0.48 0.50 0.5 0.29 0.45 0.30 0.46 0.22 0.42 0.58 0.49 0.18 0.38 0.15 0.36 0.35 0.48 
12 
0.15 0.35 0.10 0.30 0.14 0.35 0.09 0.28 0.17 0.37 0.17 0.37 0.25 0.43 0.16 0.37 0.19 0.39 0.08 0.27 0.15 0.35 0.18 0.39 0.15 0.36 0.20 0.40 0.15 0.36 
13 
0.37 0.48 0.41 0.49 0.42 0.49 0.25 0.44 0.35 0.48 0.46 0.50 0.46 0.50 0.45 0.5 0.43 0.50 0.32 0.47 0.27 0.44 0.36 0.48 0.28 0.45 0.30 0.46 0.38 0.47 
14 
0.45 0.50 0.47 0.50 0.38 0.49 0.59 0.49 0.29 0.45 0.42 0.49 0.50 0.50 0.68 0.47 0.25 0.43 0.42 0.49 0.56 0.50 0.73 0.45 0.38 0.49 0.38 0.49 0.42 0.49 
15 
0.35 0.48 0.41 0.49 0.28 0.45 0.16 0.36 0.25 0.44 0.34 0.48 0.38 0.49 0.38 0.49 0.53 0.50 0.35 0.48 0.47 0.50 0.26 0.44 0.34 0.47 0.32 0.47 0.37 0.48 
16 
0.30 0.46 0.36 0.48 0.30 0.46 0.24 0.43 0.34 0.47 0.31 0.46 0.40 0.49 0.28 0.45 0.21 0.41 0.25 0.44 0.26 0.44 0.43 0.50 0.18 0.39 0.16 0.37 0.29 0.45 
17 
0.30 0.46 0.24 0.43 0.24 0.43 0.19 0.40 0.21 0.41 0.44 0.50 0.36 0.48 0.72 0.45 0.22 0.41 0.23 0.42 0.46 0.50 0.55 0.50 0.19 0.39 0.11 0.32 0.29 0.45 
18 
0.23 0.42 0.12 0.33 0.17 0.38 0.06 0.24 0.15 0.36 0.16 0.36 0.26 0.44 0.22 0.42 0.12 0.33 0.22 0.41 0.14 0.34 0.37 0.48 0.26 0.44 0.22 0.42 0.20 0.39 
19 
0.27 0.44 0.13 0.33 0.19 0.39 0.11 0.31 0.17 0.37 0.36 0.48 0.29 0.46 0.31 0.46 0.07 0.26 0.20 0.40 0.11 0.32 0.23 0.42 0.15 0.36 0.14 0.35 0.20 0.40 
20 
0.24 0.43 0.17 0.38 0.14 0.35 0.14 0.35 0.17 0.38 0.29 0.45 0.29 0.45 0.39 0.49 0.31 0.46 0.20 0.40 0.21 0.41 0.33 0.47 0.17 0.38 0.17 0.37 0.24 0.43 
21 
0.34 0.47 0.35 0.48 0.31 0.46 0.18 0.39 0.25 0.43 0.28 0.45 0.33 0.47 0.38 0.49 0.16 0.36 0.28 0.45 0.22 0.42 0.38 0.49 0.15 0.36 0.12 0.33 0.28 0.45 
22 
0.48 0.5 0.54 0.50 0.43 0.50 0.47 0.50 0.37 0.48 0.59 0.49 0.51 0.50 0.66 0.47 0.04 0.20 0.48 0.50 0.48 0.50 0.52 0.50 0.46 0.50 0.42 0.49 0.40 0.49 
Subscales                               
POS 2.41 2.07 2.21 1.79 2.21 1.88 1.62 1.71 2.57 1.92 2.18 1.84 2.86 2.09 3.09 1.81 2.97 1.55 1.99 1.87 2.10 1.80 2.69 1.90 1.71 1.84 1.52 1.62 2.44 1.93 
INT 2.79 2.42 2.86 2.09 2.29 2.24 2.28 1.79 2.32 1.99 2.82 2.20 2.99 2.36 3.92 2.11 1.79 1.63 2.58 2.28 2.90 2.23 3.86 2.08 2.18 2.13 1.95 1.94 2.58 2.35 
DIS 1.55 1.70 1.57 1.41 1.30 1.46 1.08 1.38 1.26 1.51 1.82 1.53 1.88 1.80 2.30 1.62 1.62 1.41 1.28 1.53 1.10 1.34 1.84 1.68 1.06 1.47 1.03 1.44 1.51 1.59 
Total score 6.74 4.99 6.64 3.91 5.80 4.27 4.98 3.83 6.15 4.04 6.82 4.29 7.73 4.89 9.31 4.16 6.37 3.46 5.85 4.43 6.09 4.17 8.39 4.65 4.95 4.28 4.50 3.79 6.54 4.50 
 
Note. SD = Standard Deviation; POS = Positive; INT = Interpersonal; DIS = Disorganized
Table 3 
 
Omega coefficients for the SPQ-B scores across countries and total sample 
SPQ-B US Spain NZ Italy Australia Belgium UK Tunisia China Canada Greece Mauritus Austria Germany Total 
Positive 0.88 0.84 0.87 0.87 0.84 0.85 0.86 0.79 0.77 0.87 0.88 0.83 0.88 0.91 0.86 
Interpersonal 0.93 0.90 0.93 0.89 0.88 0.91 0.92 0.85 0.88 0.92 0.92 0.86 0.92 0.94 0.91 
Disorganization 0.91 0.85 0.92 0.91 0.91 0.84 0.93 0.85 0.88 0.90 0.90 0.86 0.92 0.94 0.89 
Total Score 0.94 0.89 0.93 0.93 0.91 0.91 0.93 0.88 0.89 0.93 0.92 0.91 0.92 0.93 0.92 
Note. NZ= New Zealand
Table 4 
Goodness-of-fit indices of the models tested in the confirmatory factor analysis 
χ2 df CFI TLI RMSEA (90% CI) WRMR 
Model a: Unidimensional 
US 13644.01 209 .820 .801 .085 (.084-.081) 6.825 
Spain 5375.73 209 .700 .668 .090 (.088-.092) 4.469 
New Zealand 2717.42 209 .775 .751 .084 (.081-087) 3.178 
Italy 743.17 209 .826 .808 .063 (.058-.068) 1.709 
Australia 2730.01 209 .740 .713 .079 (.076-.082) 3.220 
Belgium 1505.39 209 .748 .722 .083 (.079-.087) 2.423 
UK 2654.50 209 .761 .736 .099 (.095-.010) 3.188 
Tunisia 598.52 209 .783 .754 .064 (.061-.066) 1.523 
China 4309.68 209 .772 .751 .064 (.062-.067) 3.904 
Canada 3036.70 209 .785 .762 .086 (.083-.088) 3.371 
Greece 1578.64 209 .793 .774 .080 (.079-.082) 2.475 
Mauritus 741.28 209 .921 .912 .046 (.042-.050) 1.564 
Austria 721.908 209 .803 .782 .079 (.073-.086) 1.727 
Germany 971.177 209 .749 .723 .077 (.072-.082) 1.998 
Total sample 42494.65 209 .768 .743 .084 (.084-.085) 12.104 
Model b:Bidimensional 
US 14069.65 208 .855 .839 .080 (.079-.081) 6.960 
Spain 1479.03 208 .742 .713 .074 (.070-.077) 2.423 
New Zealand 2285.08 208 .814 .793 .077 (.074-.080) 2.921 
Italy 667.05 208 .850 .834 .058 (.053-.063) 1.611 
Australia 2430.40 208 .774 .748 .072 (.068-.074) 3.042 
Belgium 1357.85 208 .783 .749 .078 (.074-.081) 2.305 
UK 2.293.71 208 .796 .774 .091 (.088-.095) 2.968 
Tunisia 525.48 208 .817 .796 .058 (.052-.064) 1.415 
China 3870.22 208 .796 .773 .060 (.058-.062) 3.703 
Canada 2456.85 208 .829 .810 .076 (.074-.079) 3.035 
Greece 1205.26 208 .853 .838 .073 (.068-.075) 2.164 
Mauritus 608.31 208 .940 .934 .040 (.036-.044) 1.412 
Austria 580.94 208 .856 .841 .069 (.061-.074) 1.531 
Germany 801.94 208 .805 .783 .068 (.063-.073) 1.814 
Total sample 37064.26 208 .797 .775 .079 (.078-.080) 11.325 
Model c: Three factor model 
US 8297.27 202 .915 .903 .062 (.061-.063) 5.184 
Spain 990.75 202 .840 .820 .059 (.055-.063) 1.943 
New Zealand 1336.89 202 .900 .880 .058 (.055-.060) 2.186 
Italy 414.88 202 .931 .921 .040 (.035-.046) 1.211 
Australia 1180.56 202 .899 .885 .050 (.047-.053) 2.054 
Belgium 897.01 202 .865 .846 .062 (.058-.066) 1.820 
UK 1444.63 202 .897 .861 .072 (.068-.075) 2.285 
Tunisia 396.64 202 .871 .871 .046 (.039-.053) 1.195 
China 2847.80 202 .852 .831 .052 (.050-.053) 3.170 
Canada 1482.74 202 .903 .889 .059 (.056-.061) 2.291 
Greece 872.69 202 .899 .884 .056 (.053-.060) 1.790 
Mauritus 521.96 202 .952 .945 .036 (.033-.040) 1.292 
Austria 374.84 202 .933 .924 .047 (.039-.054) 1.154 
Germany 482.39 202 .908 .895 .048 (.042-.053) 1.342 
Total sample 22683.56 202 .876 .859 .063 (.062-.063) 8.727 
Model d:Three factor model (no overlap)     
US 10267.63 206 .895 .882 .068 (.067-.069) 5.860 
Spain 1245.25 206 .789 .763 .067 (.063-.071) 2.208 
New Zealand 1675.86 206 .868 .852 .065 (.062-.068) 2.476 
Italy 510.998 206 .901 .889 .048 (.043-.053) 1.383 
Australia 1474.20 206 .869 .853 .056 (.054-.059) 2.333 
Belgium 1020.36 206 .842 .823 .067 (.062-.071) 1.971 
UK 1.656.99 206 .858 .841 .077 (.073-.080) 2.484 
Tunisia 418.60 206 .877 .862 .047 (.041-.054) 1.246 
China 3552.65 206 .813 .791 .058 (.056-.059) 3.541 
Canada 1809.23 206 .878 .863 .065 (.062-.068) 2.572 
Greece 1124.98 206 .861 .845 .065 (.062-.069) 2.063 
Mauritus 614.40 206 .939 .932 .041 (.037-.044) 1.414 
Austria 484.997 206 .893 .880 .059 (.052-.066) 1.362 
Germany 701.291 206 .837 .817 .063 (.058-.068) 1.671 
Total sample 28597.38 206 .844 .825 .070 (.069-.070) 9.878 
Model e: bifactor       
US 5847.31 187 .941 .927 .054 (.053-.055) 4.123 
Spain 687.21 187 .898 .875 .049 (.045-.053 1.544 
New Zealand 902.85 187 .936 .921 .047 (.044-.051) 1.695 
Italy 338.92 187 .950 .939 .035 (.029-.041) 1.051 
Australia 1036.82 187 .912 .892 .049 (.046-.051) 1.830 
Belgium 695.55 187 .901 .878 .055 (.051-.060) 1.532 
UK 957.491 187 .925 .907 .059 (.055-.062) 1.749 
Tunisia 339.87 187 .912 .891 .042 (.035-.049) 1.072 
China 2124.12 187 .892 .866 .046 (.044-.048) 2.640 
Canada 1006.38 187 .938 .923 .049 (.046-.052) 1.780 
Greece 709.26 187 .921 .903 .052 (.048-.056) 1.547 
Mauritus 415.24 187 .966 .958 .032 (.028-.036) 1.127 
Austria 299.357 187 .957 .947 .039 (.031-.047) .956 
Germany 373.595 187 .939 .924 .040 (.034-.046) 1.102 
Total sample 17695.42 187 .904 .881 .057 (.057-.058) 7.357 
Note. χ2 = Chi square; df = degrees of freedom; CFI = Comparative Fit Index; TLI = 
Tucker-Lewis Index; RMSEA = Root Mean Square Error of Approximation; CI = 
Confidence Interval; WRMR= Weighted Root Mean Square Residual.
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Table 5 
Factor loadings for the Bifactor model. 
 US Spain NZ Italy Australia Belgium UK Tunisia China Canada Greece Mauritus Austria Germany Total sample Across samples 
General factor                Mean Range 
1 0.68 0.47 0.73 0.39 0.37 0.57 0.64 0.42 0.53 0.61 0.54 0.66 0.66 0.54 0.58 0.55 0.37-0.73 
2 0.32 0.18 0.18 0.33 0.23 0.19 0.27 0.21 0.20 0.24 0.22 0.51 0.51 0.30 0.27 0.25 0.18-0.50 
3 0.57 0.37 0.41 0.67 0.53 0.56 0.50 0.44 0.54 0.47 0.49 0.63 0.63 0.49 0.54 0.51 0.37-0.67 
4 0.38 0.22 0.33 0.49 0.37 0.27 0.30 0.18 0.07 0.30 0.15 0.33 0.33 0.49 0.20 0.28 0.07-0.49 
5 0.34 0.23 0.30 0.47 0.39 0.32 0.33 0.31 0.12 0.31 0.29 0.31 0.31 0.45 0.22 0.31 0.12-0.47 
6 0.60 0.31 0.50 0.63 0.50 0.77 0.57 0.51 0.73 0.51 0.45 0.72 0.72 0.52 0.57 0.56 0.31-0.77 
7 0.71 0.70 0.74 0.59 0.68 0.63 0.66 0.33 0.51 0.73 0.74 0.57 0.57 0.89 0.65 0.63 0.33-0.74 
8 0.78 0.57 0.70 0.73 0.62 0.55 0.75 0.57 0.62 0.72 0.58 0.70 0.70 0.64 0.67 0.66 0.55-0.73 
9 0.56 0.54 0.56 0.71 0.57 0.57 0.46 0.56 0.67 0.55 0.54 0.59 0.59 0.84 0.59 0.57 0.43-0.71 
10 0.46 0.35 0.33 0.57 0.33 0.43 0.46 0.37 0.37 0.41 0.45 0.47 0.47 0.29 0.44 0.42 0.33-0.57 
11 0.51 0.33 0.42 0.44 0.23 0.36 0.47 0.39 0.38 0.42 0.60 0.42 0.42 0.59 0.44 0.42 0.23-0.59 
12 0.31 0.17 0.17 0.33 0.23 0.16 0.14 0.30 0.17 0.27 0.21 0.32 0.32 0.36 0.25 0.22 0.05-0.33 
13 0.57 0.31 0.40 0.63 0.50 0.39 0.47 0.61 0.24 0.51 0.51 0.54 0.54 0.43 0.48 0.47 0.31-0.63 
14 0.67 0.66 0.69 0.43 0.54 0.64 0.66 0.35 0.43 0.66 0.68 0.53 0.53 0.58 0.59 0.58 0.35-0.69 
15 0.53 0.43 0.53 0.43 0.25 0.48 0.41 0.47 0.21 0.43 0.50 0.42 0.42 0.48 0.40 0.42 0.21-0.50 
16 0.52 0.34 0.39 0.45 0.42 0.47 0.52 0.35 0.38 0.50 0.45 0.50 0.50 0.58 0.50 0.44 0.38-0.50 
17 0.64 0.64 0.56 0.72 0.57 0.47 0.60 0.28 0.45 0.59 0.63 0.51 0.51 0.63 0.62 0.56 0.45-0.72 
18 0.69 0.61 0.65 0.34 0.53 0.55 0.67 0.59 0.70 0.67 0.66 0.34 0.34 0.63 0.63 0.59 0.34-0.73 
19 0.66 0.46 0.61 0.59 0.59 0.56 0.61 0.69 0.74 0.63 0.52 0.65 0.65 0.58 0.65 0.61 0.46-0.74 
20 0.78 0.65 0.75 0.75 0.70 0.78 0.76 0.73 0.73 0.76 0.74 0.67 0.67 0.72 0.75 0.73 0.65-0.78 
21 0.54 0.38 0.43 0.50 0.38 0.37 0.45 0.46 0.47 0.47 0.60 0.53 0.53 0.69 0.47 0.47 0.37-0.60 
22 0.55 0.57 0.57 0.18 0.35 0.45 0.58 0.15 0.59 0.57 0.60 0.46 0.46 0.61 0.47 0.47 0.15-0.62 
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Latent factors                  
Positive                  
2 0.64 0.65 0.69 0.71 0.42 0.57 0.70 0.73 0.60 0.61 0.76 0.39 0.81 0.92 0.58 0.66 0.39-0.92 
4 0.45 0.40 0.41 0.27 0.44 0.42 0.41 0.42 0.47 0.46 0.32 0.39 0.51 0.51 0.55 0.42 0.27-0.51 
5 0.63 0.61 0.59 0.48 0.63 0.66 0.61 0.50 0.60 0.65 0.67 0.41 0.60 0.68 0.70 0.59 0.41-0.68 
9 0.04 0.26 0.30 0.12 0.24 0.25 0.29 0.29 0.09 0.38 0.35 0.28 0.18 0.11 0.19 0.23 0.04-0.38 
10 0.32 0.32 0.28 0.17 0.43 0.24 0.27 0.23 0.22 0.39 0.31 0.24 0.10 0.18 0.23 0.26 0.10-0.39 
12 0.51 0.59 0.64 0.65 0.35 0.70 0.58 0.45 0.30 0.47 0.61 0.35 0.84 0.69 0.49 0.55 0.30-0.84 
16 0.42 0.43 0.40 0.30 0.41 0.31 0.35 0.41 0.37 0.41 0.37 0.11 0.27 0.40 0.31 0.35 0.11-0.43 
17 0.21 0.18 0.22 0.09 0.13 0.57 0.24 0.26 0.08 0.24 0.18 0.19 0.20 0.08 0.11 0.21 0.08-0.57 
Interpersonal                  
1 0.18 0.34 0.22 0.42 0.25 0.33 0.07 0.31 0.28 0.18 0.22 -0.03 0.38 0.31 0.22 0.25 0.01-0.33 
7 0.13 -0.12 0.16 0.09 0.31 0.16 0.22 0.18 -0.07 0.04 -0.10 0.03 -0.10 -0.11 0.19 0.06 0.03-0.24 
11 0.68 0.75 0.76 0.83 0.47 0.79 0.78 0.65 0.60 0.77 0.69 0.56 0.70 0.56 0.67 0.68 0.47-0.83 
14 0.22 0.07 0.17 0.32 0.45 0.20 0.14 0.36 0.19 0.17 -0.05 0.19 0.14 0.16 0.30 0.19 -0.05-0.45 
15 0.56 0.50 0.52 0.58 0.62 0.50 0.56 0.53 0.49 0.61 0.45 0.33 0.52 0.56 0.46 0.52 0.33-0.62 
18 0.27 0.28 0.37 0.30 0.53 0.28 0.29 0.27 0.39 0.30 0.36 0.25 0.39 0.37 0.35 0.33 0.25-0.53 
21 0.72 0.85 0.76 0.68 0.59 0.86 0.84 0.66 0.62 0.78 0.72 0.71 0.58 0.54 0.75 0.71 0.59-0.86 
22 0.39 0.17 0.36 0.45 0.63 0.35 0.29 0.50 0.53 0.38 0.19 0.31 0.23 0.34 0.44 0.37 0.17-0.63 
Disorganized                  
3 0.44 0.40 0.64 0.35 0.52 0.31 0.53 0.08 0.26 0.56 0.57 -0.09 0.54 0.51 0.42 0.40 0.08-0.64 
6 0.70 0.74 0.70 0.54 0.77 0.62 0.74 0.44 0.44 0.70 0.78 0.05 0.74 0.75 0.65 0.62 0.05-0.78 
8 0.04 0.09 0.04 -0.25 0.18 -0.15 0.08 0.06 -0.27 0.09 0.20 0.05 0.36 0.21 -0.02 0.05 0.04-0.27 
13 0.36 0.28 0.38 0.10 0.33 -0.20 0.46 -0.25 0.17 0.39 0.33 0.12 0.45 0.44 0.29 0.24 0.09-0.52 
19 0.54 0.79 0.59 0.58 0.65 0.42 0.54 0.49 0.40 0.57 0.55 0.07 0.70 0.57 0.49 0.53 0.07-0.79 
20 -0.11 -0.02 -0.07 -0.20 -0.08 -0.32 -0.07 -0.38 -0.54 -0.07 -0.10 0.95 0.13 0.17 -0.16 0.05 0.01 -0.95 
 
9 
 
Table 6 
 
Factor loadings for the Raine et al. (1994) model 
Items Us Spain NZ Italy Australia Belgium UK Tunisia China Canada greece Mauritus Austria Germany 
Total  
sample across samples  
                Mean Range 
Positive                  
2 0.60 0.53 0.54 0.54 0.43 0.47 0.58 0.57 0.49 0.53 0.60 0.63 0.72 0.74 0.55 0.57 0.43-0.74 
4 0.60 0.45 0.57 0.61 0.59 0.50 0.52 0.40 0.31 0.53 0.32 0.43 0.73 0.69 0.46 0.52 0.31-0.73 
5 0.62 0.56 0.63 0.64 0.68 0.64 0.61 0.58 0.41 0.61 0.64 0.42 0.76 0.78 0.54 0.61 0.41-0.78 
7 0.31 0.46 0.29 0.42 0.34 0.31 0.26 0.21 0.37 0.38 0.36 0.52 0.49 0.35 0.23 0.36 0.20-0.52 
9 0.54 0.56 0.50 0.58 0.53 0.55 0.48 0.52 0.40 0.59 0.59 0.55 0.51 0.31 0.46 0.51 0.39-0.59 
10 0.63 0.53 0.52 0.66 0.54 0.57 0.62 0.51 0.54 0.61 0.64 0.56 0.35 0.32 0.59 0.54 0.51-0.64 
12 0.54 0.49 0.50 0.55 0.41 0.50 0.41 0.55 0.38 0.49 0.53 0.41 0.81 0.61 0.49 0.51 0.38-0.81 
14 0.22 0.25 0.27 0.18 0.14 0.27 0.28 0.08 0.12 0.29 0.31 0.30 0.06 0.17 0.13 0.21 0.06-0.31 
16 0.75 0.59 0.64 0.56 0.62 0.65 0.73 0.59 0.63 0.72 0.70 0.56 0.73 0.70 0.71 0.66 0.56-0.75 
17 0.46 0.52 0.45 0.58 0.38 0.47 0.46 0.38 0.34 0.52 0.45 0.50 0.42 0.30 0.357 0.44 0.38-0.58 
Interpersonal                 
1 0.74 0.61 0.78 0.60 0.48 0.70 0.66 0.56 0.65 0.67 0.61 0.70 0.67 0.67 0.66 0.65 0.48-0.78 
7 0.53 0.35 0.61 0.29 0.59 0.49 0.57 0.28 0.29 0.47 0.48 0.11 0.50 0.60 0.57 0.44 0.11-0.61 
9 0.52 0.21 0.29 0.28 0.23 0.23 0.17 0.26 0.47 0.19 0.21 0.15 0.50 0.57 0.31 0.31 0.15-0.57 
11 0.79 0.73 0.76 0.88 0.47 0.81 0.87 0.70 0.60 0.79 0.87 0.60 0.84 0.77 0.73 0.75 0.47-0.87 
14 0.59 0.52 0.58 0.45 0.67 0.54 0.52 0.46 0.45 0.52 0.48 0.32 0.58 0.52 0.63 0.52 0.32-0.57 
15 0.73 0.65 0.73 0.73 0.59 0.72 0.64 0.72 0.40 0.69 0.65 0.53 0.65 0.68 0.59 0.65 0.40-0.73 
17 0.35 0.33 0.31 0.28 0.65 0.20 0.32 0.08 0.28 0.25 0.38 0.10 0.36 0.50 0.41 0.31 0.08-0.65 
18 0.79 0.71 0.78 0.49 0.80 0.66 0.77 0.70 0.87 0.78 0.77 0.43 0.75 0.73 0.77 0.72 0.43-0.87 
21 0.82 0.80 0.77 0.87 0.68 0.84 0.88 0.77 0.71 0.84 0.88 0.73 0.90 0.82 0.79 0.81 0.68-0.90 
22 0.69 0.63 0.71 0.41 0.68 0.61 0.68 0.40 0.79 0.71 0.67 0.58 0.69 0.63 0.65 0.64 0.40-0.79 
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Disorganized                 
3 0.67 0.54 0.61 0.71 0.71 0.60 0.67 0.44 0.55 0.63 0.64 0.62 0.70 0.68 0.64 0.63 0.44-0.71 
6 0.77 0.59 0.74 0.71 0.81 0.75 0.80 0.52 0.76 0.72 0.68 0.73 0.83 0.79 0.71 0.73 0.59-0.83 
8 0.80 0.63 0.74 0.71 0.66 0.56 0.78 0.57 0.64 0.76 0.66 0.72 0.78 0.79 0.68 0.70 0.57-0.79 
13 0.65 0.44 0.52 0.64 0.61 0.39 0.60 0.60 0.26 0.62 0.61 0.56 0.60 0.53 0.55 0.55 0.39-0.62 
19 0.79 0.77 0.80 0.68 0.85 0.60 0.79 0.67 0.78 0.79 0.69 0.67 0.87 0.80 0.76 0.76 0.60-0.87 
20 0.77 0.67 0.77 0.74 0.65 0.76 0.75 0.70 0.70 0.76 0.76 0.71 0.79 0.85 0.73 0.74 0.65-0.85 
Factor Correlations                 
F2-F1 0.64 0.04 0.52 0.77 0.56 0.67 0.60 0.60 0.59 0.60 0.553 0.79 0.50 0.42 0.62 0.58 0.04-0.79 
F3-F1 0.38 0.05 0.25 0.32 0.22 0.23 0.30 0.27 0.20 0.30 0.264 0.59 0.40 0.21 0.29 0.29 0.05-0.59 
F3-F2 0.70 0.04 0.61 0.57 0.47 0.62 0.59 0.68 0.73 0.62 0.656 0.80 0.61 0.67 0.65 0.59 0.04-0.80 
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